Kris MG - Search Results

1

Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trials.

Bell DW, Lynch TJ, Haserlat SM, Harris PL, Okimoto RA, Brannigan BW, Sgroi DC, Muir B, Riemenschneider MJ, Iacona RB, Krebs AD, Johnson DH, Giaccone G, Herbst RS, Manegold C, Fukuoka M, Kris MG, Baselga J, Ochs JS, Haber DA. Bell DW, et al. Among authors: kris mg. J Clin Oncol. 2005 Nov 1;23(31):8081-92. doi: 10.1200/JCO.2005.02.7078. Epub 2005 Oct 3. J Clin Oncol. 2005. PMID: 16204011 Clinical Trial.

2

Single-agent chemotherapy trials in small-cell lung cancer, 1970 to 1990: the case for studies in previously treated patients.

Grant SC, Gralla RJ, Kris MG, Orazem J, Kitsis EA. Grant SC, et al. Among authors: kris mg. J Clin Oncol. 1992 Mar;10(3):484-98. doi: 10.1200/JCO.1992.10.3.484. J Clin Oncol. 1992. PMID: 1311028

3

Limited small-cell lung cancer: do favorable short-term results predict ultimate outcome?

Armstrong J, Shank B, Scher H, Gaynor J, Martini N, Kutcher J, Kris M. Armstrong J, et al. Am J Clin Oncol. 1991 Aug;14(4):285-90. Am J Clin Oncol. 1991. PMID: 1650527

4

Phase II trial of amonafide in patients with stage III and IV non-small-cell lung cancer.

Berger MZ, Kris MG, Gralla RJ, Marks LD, Potanovich LM, Dimaggio JJ, Heelan RT. Berger MZ, et al. Among authors: kris mg. Am J Clin Oncol. 1991 Apr;14(2):124-6. doi: 10.1097/00000421-199104000-00006. Am J Clin Oncol. 1991. PMID: 1851387

5

Phase II trial of trimetrexate in patients with stage III and IV non-small-cell lung cancer.

Kris MG, D'Acquisto RW, Gralla RJ, Burke MT, Marks LD, Fanucchi MP, Heelan RT. Kris MG, et al. Am J Clin Oncol. 1989 Feb;12(1):24-6. doi: 10.1097/00000421-198902000-00006. Am J Clin Oncol. 1989. PMID: 2536213

6

Phase II study of 10-ethyl-10-deaza-aminopterin in patients with stage III and IV non-small-cell lung cancer.

Shum KY, Kris MG, Gralla RJ, Burke MT, Marks LD, Heelan RT. Shum KY, et al. Among authors: kris mg. J Clin Oncol. 1988 Mar;6(3):446-50. doi: 10.1200/JCO.1988.6.3.446. J Clin Oncol. 1988. PMID: 2832548

7

Chemotherapy in non-small cell lung cancer: results of recent trials.

Gralla RJ, Kris MG. Gralla RJ, et al. Among authors: kris mg. Semin Oncol. 1988 Jun;15(3 Suppl 4):2-5. Semin Oncol. 1988. PMID: 2839904 Review.

8

Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy.

O'Connell JP, Kris MG, Gralla RJ, Groshen S, Trust A, Fiore JJ, Kelsen DP, Heelan RT, Golbey RB. O'Connell JP, et al. Among authors: kris mg. J Clin Oncol. 1986 Nov;4(11):1604-14. doi: 10.1200/JCO.1986.4.11.1604. J Clin Oncol. 1986. PMID: 3021920

9

Ifosfamide plus high-dose cisplatin in patients with non-small cell lung cancer previously treated with chemotherapy.

Miller VA, Rigas JR, Pisters KM, Grant SC, Pfister DG, Heelan RT, Kris MG. Miller VA, et al. Among authors: kris mg. Am J Clin Oncol. 1995 Aug;18(4):303-6. doi: 10.1097/00000421-199508000-00007. Am J Clin Oncol. 1995. PMID: 7625371 Clinical Trial.

10

Syndrome of acute dyspnea related to combined mitomycin plus vinca alkaloid chemotherapy.

Rivera MP, Kris MG, Gralla RJ, White DA. Rivera MP, et al. Among authors: kris mg. Am J Clin Oncol. 1995 Jun;18(3):245-50. doi: 10.1097/00000421-199506000-00012. Am J Clin Oncol. 1995. PMID: 7747713

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

519 results

Search Page